Serum 25-hydroxyvitamin d concentrations and their impact on all-cause mortality in parkinson’s disease: insights from national health and nutrition examination survey 1999–2020 data

HIGHLIGHTS

• What: This model showed that the mortality risk for Group 1 was 3.52 times higher than that of Group 3 (95% CI=1.58-7.86, p=0.002), and the risk for Group 4 was 2.92 times higher (95% CI=1.06-8.05, p=0.038).
• Who: Yufei Yong from the (CNR), Italy University of Kentucky, United States have published the paper: Serum 25-hydroxyvitamin D concentrations and their impact on all-cause mortality in Parkinson’s disease: insights from National Health and Nutrition Examination Survey 1999-2020 data, in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.